Literature DB >> 26141987

Branched-chain amino acids ameliorate heart failure with cardiac cachexia in rats.

Yohei Tanada1, Tetsuo Shioi2, Takao Kato3, Akira Kawamoto1, Junji Okuda1, Takeshi Kimura1.   

Abstract

AIMS: Heart failure (HF) is associated with changes in energy metabolism of the heart, as well as in extra-cardiac organs such as the skeletal muscles. Cardiac cachexia is a common complication and is associated with poor prognosis. Branched-chain amino acids (BCAAs) reportedly improve sarcopenia and cancer cachexia. We tested the hypothesis that BCAA ameliorates HF with cardiac cachexia. MAIN
METHODS: We used Dahl salt-sensitive (DS) rats fed a high-salt diet as a model of HF. DS rats fed a low-salt diet were used as a control. BCAA were administered in drinking water from 11weeks of age, when cardiac hypertrophy was established but the cardiac function was preserved. Survival and the cardiac function were monitored, and animals were sacrificed at 21weeks of age and analyzed. KEY
FINDINGS: In HF rats, BCAA treatment decreased the heart rate, preserved the cardiac function, and prolonged survival. BCAA also prevented body weight loss, associated with preservation of the skeletal muscle weight. Moreover, gene expression related to mitochondrial biogenesis and function was increased with BCAA in skeletal muscles. SIGNIFICANCE: BCAA preserved the body weight and cardiac function and prolonged survival in HF rats. The expression of genes involved in mitochondrial biogenesis and function in skeletal muscles was increased by BCAA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Branched-chain amino acids; Cachexia; Heart failure

Mesh:

Substances:

Year:  2015        PMID: 26141987     DOI: 10.1016/j.lfs.2015.06.021

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  28 in total

1.  Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.

Authors:  Haipeng Sun; Kristine C Olson; Chen Gao; Domenick A Prosdocimo; Meiyi Zhou; Zhihua Wang; Darwin Jeyaraj; Ji-Youn Youn; Shuxun Ren; Yunxia Liu; Christoph D Rau; Svati Shah; Olga Ilkayeva; Wen-Jun Gui; Noelle S William; R Max Wynn; Christopher B Newgard; Hua Cai; Xinshu Xiao; David T Chuang; Paul Christian Schulze; Christopher Lynch; Mukesh K Jain; Yibin Wang
Journal:  Circulation       Date:  2016-04-08       Impact factor: 29.690

Review 2.  Publication trends in cachexia and sarcopenia in elderly heart failure patients.

Authors:  Jochen Springer; Stefan D Anker
Journal:  Wien Klin Wochenschr       Date:  2016-11-24       Impact factor: 1.704

3.  Metabolic remodeling of substrate utilization during heart failure progression.

Authors:  Liang Chen; Jiangping Song; Shengshou Hu
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

4.  Impact of Melatonin and Branched-Chain Amino Acids Cosupplementation on Quality of Life, Fatigue, and Nutritional Status in Cachectic Heart Failure Patients: A Randomized Controlled Trial.

Authors:  Hamed Jafari-Vayghan; Jalal Moludi; Sevda Saleh-Ghadimi; Elgar Enamzadeh; Mir Hossein Seyed-Mohammadzad; Mohammad Alizadeh
Journal:  Am J Lifestyle Med       Date:  2019-09-14

5.  Feasibility of Conducting a 6-month long Home-based Exercise Program with Protein Supplementation in Elderly Community-dwelling Individuals with Heart Failure.

Authors:  Masil George; Gohar Azhar; Amanda Pangle; Eric Peeler; Amanda Dawson; Robert Coker; Kellie S Coleman; Amy Schrader; Jeanne Wei
Journal:  J Physiother Phys Rehabil       Date:  2017-04-24

Review 6.  Interplay Between Reactive Oxygen/Reactive Nitrogen Species and Metabolism in Vascular Biology and Disease.

Authors:  Masuko Ushio-Fukai; Dipankar Ash; Sheela Nagarkoti; Eric J Belin de Chantemèle; David J R Fulton; Tohru Fukai
Journal:  Antioxid Redox Signal       Date:  2021-06-01       Impact factor: 7.468

Review 7.  Cardiac Cachexia: Perspectives for Prevention and Treatment.

Authors:  Marina Politi Okoshi; Rafael Verardino Capalbo; Fernando G Romeiro; Katashi Okoshi
Journal:  Arq Bras Cardiol       Date:  2016-10-27       Impact factor: 2.000

8.  An exploratory study on the efficacy and safety of a BCAA preparation used in combination with cardiac rehabilitation for patients with chronic heart failure.

Authors:  Munenori Takata; Eisuke Amiya; Masafumi Watanabe; Yumiko Hosoya; Atsuko Nakayama; Takayuki Fujiwara; Masanobu Taya; Gaku Oguri; Kanako Hyodo; Naoko Takayama; Nami Takano; Tomoe Mashiko; Yukari Uemura; Issei Komuro
Journal:  BMC Cardiovasc Disord       Date:  2017-07-27       Impact factor: 2.298

9.  MiR30-GALNT1/2 Axis-Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts.

Authors:  Yasuaki Nakagawa; Toshio Nishikimi; Koichiro Kuwahara; Aoi Fujishima; Shogo Oka; Takayoshi Tsutamoto; Hideyuki Kinoshita; Kazuhiro Nakao; Kosai Cho; Hideaki Inazumi; Hiroyuki Okamoto; Motohiro Nishida; Takao Kato; Hiroyuki Fukushima; Jun K Yamashita; Wino J Wijnen; Esther E Creemers; Kenji Kangawa; Naoto Minamino; Kazuwa Nakao; Takeshi Kimura
Journal:  J Am Heart Assoc       Date:  2017-02-10       Impact factor: 5.501

10.  The metabolic profile of a rat model of chronic kidney disease.

Authors:  Yohei Tanada; Junji Okuda; Takao Kato; Eri Minamino-Muta; Ichijiro Murata; Tomoyoshi Soga; Tetsuo Shioi; Takeshi Kimura
Journal:  PeerJ       Date:  2017-05-23       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.